UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Cancer, 2004-04, Vol.100 (7), p.1397-1405

2004

Volltextzugriff (PDF)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

European urology open science (Online), 2021-08, Vol.30, p.25-33

2021

Volltextzugriff (PDF)

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

European urology open science (Online), 2020-07, Vol.20, p.54-61

2020

Volltextzugriff (PDF)

Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial

The Journal of urology, 2010-09, Vol.184 (3), p.984-989

2010

Volltextzugriff (PDF)

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

The New England journal of medicine, 2022-12, Vol.387 (23), p.2126-2137

2022

Volltextzugriff (PDF)

Stopping screening, when and how?

Translational andrology and urology, 2018-02, Vol.7 (1), p.46-53

Hugosson, Jonas

2018

Volltextzugriff (PDF)

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study

BMJ (Online), 2014-03, Vol.348 (mar28 1), p.g2296-g2296

2014

Volltextzugriff (PDF)

Overdetection in screening for prostate cancer

Current opinion in urology, 2014-05, Vol.24 (3), p.256-263

2014

Volltextzugriff (PDF)

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.235-239

2006

Volltextzugriff (PDF)

Outcome Following Active Surveillance of Men with Screen-detected Prostate Cancer. Results from the Göteborg Randomised Population-based Prostate Cancer Screening Trial

European urology, 2013-01, Vol.63 (1), p.101-107

2013

Volltextzugriff (PDF)

The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial

European urology, 2022-09, Vol.82 (3), p.311-317

2022

Volltextzugriff (PDF)

Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review

European urology, 2015-04, Vol.67 (4), p.627-636

2015

Volltextzugriff (PDF)

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

European urology, 2024-08, Vol.86 (2), p.95-100

2024

Volltextzugriff (PDF)

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

The Journal of urology, 2022-08, Vol.208 (2), p.292-300

2022

Volltextzugriff (PDF)

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

JNCI : Journal of the National Cancer Institute, 2010-07, Vol.102 (13), p.950-958

2010

Volltextzugriff (PDF)

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Journal of magnetic resonance imaging, 2022-03, Vol.55 (3), p.842-853

2022

Volltextzugriff (PDF)

Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men

European urology, 2024-03, Vol.85 (3), p.207-214

2024

Volltextzugriff (PDF)

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

European urology, 2024-09, Vol.86 (3), p.223-229

2024

Volltextzugriff (PDF)

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial

The Journal of urology, 2022-11, Vol.208 (5), p.1018-1027

2022

Volltextzugriff (PDF)

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

Cancer epidemiology, biomarkers & prevention, 2009-07, Vol.18 (7), p.2000-2005

2009

Volltextzugriff (PDF)

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

Scandinavian journal of urology, 2021-03, Vol.55 (2), p.116-124

2021

Volltextzugriff (PDF)

Results after Four Years of Screening for Prostate Cancer with PSA and MRI

The New England journal of medicine, 2024-09, Vol.391 (12), p.1083-1095

2024

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767–8

European urology, 2016-11, Vol.70 (5), p.769-770

2016

Volltextzugriff (PDF)

26 – 50 von 345

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

Englisch
(337)
Schwedisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Stopping screening, when and how?

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study

Overdetection in screening for prostate cancer

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Outcome Following Active Surveillance of Men with Screen-detected Prostate Cancer. Results from the Göteborg Randomised Population-based Prostate Cancer Screening Trial

The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial

Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

Results after Four Years of Screening for Prostate Cancer with PSA and MRI

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767–8

Aktive Filter

Suchergebnisse filtern